We are analyzing https://link.springer.com/article/10.1007/s00401-009-0547-7.

Title:
Evaluation of subcortical pathology and clinical correlations in FTLD-U subtypes | Acta Neuropathologica
Description:
Frontotemporal lobar degeneration (FTLD) can be classified as tau-positive (FTLD-tau) and tau-negative FTLD. The most common form of tau-negative FTLD is associated with neuronal inclusions that are composed of TAR DNA-binding protein 43 (TDP-43) (FTLD-TDP). Recent evidence suggests that FTLD-TDP can be further subdivided into at least three major histologic variants based on patterns of TDP-43 immunoreactive neuronal cytoplasmic inclusions (NCI) and dystrophic neurites (DN) in neocortex and hippocampus. The aim of this study was to extend the histologic analysis to other brain regions and to determine if there were distinct clinical and pathologic characteristics of the FTLD-TDP subtypes. Thirty-nine FTLD-TDP cases were analyzed (Mackenzie type 1 n = 24, Mackenzie type 2 n = 9, Mackenzie type 3 n = 6). There was a highly significant association between clinical syndrome and FTLD-TDP subtype, with progressive non-fluent aphasia associated with type 1, semantic dementia with type 2, and behavioral variant frontotemporal dementia with types 1, 2 and 3. Semi-quantitative analysis of NCI and DN demonstrated different patterns of involvement in cortical, subcortical and brainstem areas that were characteristic for each of the three types of FTLD-TDP. Type 1 had a mixture of NCI and DN, as well as intranuclear inclusions in most cases and TDP-43 pathology at all levels of the neuraxis, but less in brainstem than supratentorial structures. Type 2 cases were characterized by predominance of long, thick DN in the cortex, as well as numerous NCI in hippocampus, amygdala and basal ganglia, but virtually no NCI and only sparse DN in diencephalon and brainstem. Type 3 had a paucity of DN at all levels of the neuraxis and significantly more NCI in the hypoglossal nucleus than the other types. These findings extend previously described clinicopathological associations of FTLD-TDP subtypes and support the notion that FTLD-TDP subtypes may be distinct clinicopathologic disorders.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Science
Non-Profit & Charity

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We're unsure if the website is profiting.

Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Link.springer.com has a secret sauce for making money, but we can't detect it yet.

Keywords {🔍}

article, pubmed, google, scholar, frontotemporal, degeneration, lobar, neuropathol, cas, acta, josephs, dickson, dementia, clinical, disease, dois, inclusions, tdp, pathology, ftldtdp, mackenzie, neurol, type, neurology, subtypes, brain, protein, nci, cases, neuropathologic, immunohistochemistry, privacy, cookies, content, ftld, taunegative, tar, dnabinding, access, lateral, sclerosis, motor, neuron, ubiquitinpositive, analysis, publish, research, search, ftldu, stroh,

Topics {✒️}

tar dna-binding protein month download article/chapter alpha-synuclein immunohistochemical methods ubiquitin-immunoreactive neuronal inclusions ubiquitin-positive inclusions visualized ubiquitin-positive inclusions delineated full article pdf motor neuron disease josephs ka motor neuron disorders amyotrophic lateral sclerosis amyotrophic lateral sclerosis dementia brain bank article josephs related subjects frontotemporal lobar degeneration neurofilament inclusion disease cairns nj privacy choices/manage cookies argyrophilic grain disease neurodegenerative diseases tdp-43 pathologic lesions tdp-43-negative inclusions tau-negative ftld alpha-synuclein antibodies behavioral-cognitive implications ubiquitin-positive inclusions european economic area highly significant association fluent aphasia lrrk2 g2019s substitution graff-radford nr sampathu dm hodges jr monica casey-castanedes brittany dugger & dennis cerebral tdp-43 pathology conditions privacy policy article log distinct clinicopathologic disorders mackenzie ir semi-quantitative analysis accepting optional cookies ftld-tdp subtypes recent evidence suggests findings extend previously pickering-brown sm midwest-southwest consortium ubiquitin immunohistochemistry article cite

Questions {❓}

Josephs KA, Holton JL, Rossor MN et al (2003) Neurofilament inclusion body disease: a new proteinopathy?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Evaluation of subcortical pathology and clinical correlations in FTLD-U subtypes
         description:Frontotemporal lobar degeneration (FTLD) can be classified as tau-positive (FTLD-tau) and tau-negative FTLD. The most common form of tau-negative FTLD is associated with neuronal inclusions that are composed of TAR DNA-binding protein 43 (TDP-43) (FTLD-TDP). Recent evidence suggests that FTLD-TDP can be further subdivided into at least three major histologic variants based on patterns of TDP-43 immunoreactive neuronal cytoplasmic inclusions (NCI) and dystrophic neurites (DN) in neocortex and hippocampus. The aim of this study was to extend the histologic analysis to other brain regions and to determine if there were distinct clinical and pathologic characteristics of the FTLD-TDP subtypes. Thirty-nine FTLD-TDP cases were analyzed (Mackenzie type 1 n = 24, Mackenzie type 2 n = 9, Mackenzie type 3 n = 6). There was a highly significant association between clinical syndrome and FTLD-TDP subtype, with progressive non-fluent aphasia associated with type 1, semantic dementia with type 2, and behavioral variant frontotemporal dementia with types 1, 2 and 3. Semi-quantitative analysis of NCI and DN demonstrated different patterns of involvement in cortical, subcortical and brainstem areas that were characteristic for each of the three types of FTLD-TDP. Type 1 had a mixture of NCI and DN, as well as intranuclear inclusions in most cases and TDP-43 pathology at all levels of the neuraxis, but less in brainstem than supratentorial structures. Type 2 cases were characterized by predominance of long, thick DN in the cortex, as well as numerous NCI in hippocampus, amygdala and basal ganglia, but virtually no NCI and only sparse DN in diencephalon and brainstem. Type 3 had a paucity of DN at all levels of the neuraxis and significantly more NCI in the hypoglossal nucleus than the other types. These findings extend previously described clinicopathological associations of FTLD-TDP subtypes and support the notion that FTLD-TDP subtypes may be distinct clinicopathologic disorders.
         datePublished:2009-05-20T00:00:00Z
         dateModified:2009-05-20T00:00:00Z
         pageStart:349
         pageEnd:358
         sameAs:https://doi.org/10.1007/s00401-009-0547-7
         keywords:
            Frontotemporal dementia
            Frontotemporal lobar degeneration
            Immunohistochemistry
            Progressive non-fluent aphasia
            Semantic dementia
            TDP-43
            Pathology
            Neurosciences
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-009-0547-7/MediaObjects/401_2009_547_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-009-0547-7/MediaObjects/401_2009_547_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-009-0547-7/MediaObjects/401_2009_547_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-009-0547-7/MediaObjects/401_2009_547_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-009-0547-7/MediaObjects/401_2009_547_Fig5_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-009-0547-7/MediaObjects/401_2009_547_Fig6_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-009-0547-7/MediaObjects/401_2009_547_Fig7_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-009-0547-7/MediaObjects/401_2009_547_Fig8_HTML.jpg
         isPartOf:
            name:Acta Neuropathologica
            issn:
               1432-0533
               0001-6322
            volumeNumber:118
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Keith A. Josephs
               affiliation:
                     name:Mayo Clinic
                     address:
                        name:Department of Neurology, Mayo Clinic, Rochester, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Alex Stroh
               affiliation:
                     name:Mayo Clinic
                     address:
                        name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Brittany Dugger
               affiliation:
                     name:Mayo Clinic
                     address:
                        name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Dennis W. Dickson
               affiliation:
                     name:Mayo Clinic
                     address:
                        name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Evaluation of subcortical pathology and clinical correlations in FTLD-U subtypes
      description:Frontotemporal lobar degeneration (FTLD) can be classified as tau-positive (FTLD-tau) and tau-negative FTLD. The most common form of tau-negative FTLD is associated with neuronal inclusions that are composed of TAR DNA-binding protein 43 (TDP-43) (FTLD-TDP). Recent evidence suggests that FTLD-TDP can be further subdivided into at least three major histologic variants based on patterns of TDP-43 immunoreactive neuronal cytoplasmic inclusions (NCI) and dystrophic neurites (DN) in neocortex and hippocampus. The aim of this study was to extend the histologic analysis to other brain regions and to determine if there were distinct clinical and pathologic characteristics of the FTLD-TDP subtypes. Thirty-nine FTLD-TDP cases were analyzed (Mackenzie type 1 n = 24, Mackenzie type 2 n = 9, Mackenzie type 3 n = 6). There was a highly significant association between clinical syndrome and FTLD-TDP subtype, with progressive non-fluent aphasia associated with type 1, semantic dementia with type 2, and behavioral variant frontotemporal dementia with types 1, 2 and 3. Semi-quantitative analysis of NCI and DN demonstrated different patterns of involvement in cortical, subcortical and brainstem areas that were characteristic for each of the three types of FTLD-TDP. Type 1 had a mixture of NCI and DN, as well as intranuclear inclusions in most cases and TDP-43 pathology at all levels of the neuraxis, but less in brainstem than supratentorial structures. Type 2 cases were characterized by predominance of long, thick DN in the cortex, as well as numerous NCI in hippocampus, amygdala and basal ganglia, but virtually no NCI and only sparse DN in diencephalon and brainstem. Type 3 had a paucity of DN at all levels of the neuraxis and significantly more NCI in the hypoglossal nucleus than the other types. These findings extend previously described clinicopathological associations of FTLD-TDP subtypes and support the notion that FTLD-TDP subtypes may be distinct clinicopathologic disorders.
      datePublished:2009-05-20T00:00:00Z
      dateModified:2009-05-20T00:00:00Z
      pageStart:349
      pageEnd:358
      sameAs:https://doi.org/10.1007/s00401-009-0547-7
      keywords:
         Frontotemporal dementia
         Frontotemporal lobar degeneration
         Immunohistochemistry
         Progressive non-fluent aphasia
         Semantic dementia
         TDP-43
         Pathology
         Neurosciences
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-009-0547-7/MediaObjects/401_2009_547_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-009-0547-7/MediaObjects/401_2009_547_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-009-0547-7/MediaObjects/401_2009_547_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-009-0547-7/MediaObjects/401_2009_547_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-009-0547-7/MediaObjects/401_2009_547_Fig5_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-009-0547-7/MediaObjects/401_2009_547_Fig6_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-009-0547-7/MediaObjects/401_2009_547_Fig7_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-009-0547-7/MediaObjects/401_2009_547_Fig8_HTML.jpg
      isPartOf:
         name:Acta Neuropathologica
         issn:
            1432-0533
            0001-6322
         volumeNumber:118
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Keith A. Josephs
            affiliation:
                  name:Mayo Clinic
                  address:
                     name:Department of Neurology, Mayo Clinic, Rochester, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Alex Stroh
            affiliation:
                  name:Mayo Clinic
                  address:
                     name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Brittany Dugger
            affiliation:
                  name:Mayo Clinic
                  address:
                     name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Dennis W. Dickson
            affiliation:
                  name:Mayo Clinic
                  address:
                     name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Acta Neuropathologica
      issn:
         1432-0533
         0001-6322
      volumeNumber:118
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Mayo Clinic
      address:
         name:Department of Neurology, Mayo Clinic, Rochester, USA
         type:PostalAddress
      name:Mayo Clinic
      address:
         name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
         type:PostalAddress
      name:Mayo Clinic
      address:
         name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
         type:PostalAddress
      name:Mayo Clinic
      address:
         name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Keith A. Josephs
      affiliation:
            name:Mayo Clinic
            address:
               name:Department of Neurology, Mayo Clinic, Rochester, USA
               type:PostalAddress
            type:Organization
      name:Alex Stroh
      affiliation:
            name:Mayo Clinic
            address:
               name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
               type:PostalAddress
            type:Organization
      name:Brittany Dugger
      affiliation:
            name:Mayo Clinic
            address:
               name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
               type:PostalAddress
            type:Organization
      name:Dennis W. Dickson
      affiliation:
            name:Mayo Clinic
            address:
               name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Neurology, Mayo Clinic, Rochester, USA
      name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
      name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
      name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(163)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js
Semantic UI

CDN Services {📦}

Crossref

5.94s.

LINK . SPRINGER . COM {}